Noxxon Pharma
Latest round
- Series D
Last raised
- Oct 2010
Total raised
- $93M
Investors
- 11
About Noxxon Pharma
Noxxon Pharma AG, founded in 1998, operates from Berlin, Germany, and specializes in developing therapies for aggressive cancers. The company has undergone strategic pivots to enhance its R&D focus.Noxxon Pharma specializes in developing innovative therapies aimed at treating aggressive cancers by focusing on the tumor microenvironment (TME). Their core product, NOX-A12, is designed to disrupt tumor protection mechanisms, enhancing the immune system's ability to combat cancer cells. This technology works synergistically with other treatments, such as anti-VEGF therapies and radiotherapy, to improve therapeutic outcomes. The company is actively pursuing clinical applications of its products in challenging malignancies, including glioblastoma and pancreatic cancer, which have demonstrated promising preliminary results.Noxxon Pharma operates within a clinical-stage revenue model that includes partnerships and collaborations with research institutions and pharmaceutical companies. This structure may involve milestone payments contingent on clinical trial progress, as well as royalties on future product sales.4. The company aims to penetrate new markets in North America and Europe by focusing on key regions by 2025.5 million from Nyenburgh Investment Partners, will be utilized to enhance R&D efforts and accelerate the clinical development of NOX-A12 and other potential therapies.
Who invested in Noxxon Pharma
11 investors across 3 rounds
See all investors in Noxxon Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Noxxon Pharma
Who invested in Noxxon Pharma?
Noxxon Pharma has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Noxxon Pharma raised?
Noxxon Pharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Noxxon Pharma last raise money?
Noxxon Pharma's most recent round on record is a Series D, in Oct 2010.
What does Noxxon Pharma do?
Noxxon Pharma AG, founded in 1998, operates from Berlin, Germany, and specializes in developing therapies for aggressive cancers.
Where is Noxxon Pharma headquartered?
Noxxon Pharma is headquartered in Berlin, Germany.
Which VCs invest in companies like Noxxon Pharma?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Noxxon Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Noxxon Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.